Back to Search
ROSS RATNER, M.D.
M.D.
Plastic Surgery Physician
NPI: 1841588977IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
277819(NY)
Education
NEW YORK MEDICAL COLLEGE
Class of 2008
Research & Publications (20)
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.
PMID 18819705·Lancet·2009
3-trial
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
PMID 19171717·Diabetes Care·2009
2-rct
Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).
PMID 19626663·Diabetes Metab Res Rev·2009
4-observational
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
PMID 19358783·J Clin Psychiatry·2009
4-observational
Actos Now for the prevention of diabetes (ACT NOW) study.
PMID 19640291·BMC Endocr Disord·2009
8-other
Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.
PMID 19436660·Vasc Health Risk Manag·2009
2-rct
Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
PMID 19366774·JAMA·2009
2-rct
Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.
PMID 19366970·Diabetes Care·2009
3-trial
Combination pharmacotherapy with incretins: what works best and when?
PMID 18778584·Curr Diab Rep·2008
8-other
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
PMID 18826999·J Clin Endocrinol Metab·2008
2-rct
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.
PMID 19033001·Am Heart J·2008
4-observational
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
PMID 19095139·J Am Coll Cardiol·2008
3-trial
Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
PMID 18555933·Clin Ther·2008
4-observational
[Nutritional status and lifestyles of workers from two regions in Chile].
PMID 19301771·Rev Med Chil·2008
8-other
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
PMID 18398080·JAMA·2008
4-observational
Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.
PMID 17682123·Diabetes Care·2007
4-observational
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
PMID 17698614·Diabetes Care·2007
8-other
Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes.
PMID 17907111·Diab Vasc Dis Res·2007
3-trial
Prevention of type 2 diabetes in women with previous gestational diabetes.
PMID 17596479·Diabetes Care·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 53 W 36TH ST RM 205
NEW YORK, NY 10018 - Phone
- (212) 500-2163
Quick Facts
- NPI
- 1841588977
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile